Moderna said it will ask the U.S. FDA and other regulators to authorize its COVID-19 vaccine in children younger than six years old based on data showing it generated a similar immune response to adults in its clinical trial.
Suscribirse a:
Enviar comentarios (Atom)
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook